1 |
Centers for Disease Control and Prevention. Notice to readers: revised definition of extensively drug-resistant tuberculosis. MMWR Morb Mortal Wkly Rep 2006;55: 1176
|
2 |
Kim HR, Hwang SS, Kim HJ, Lee SM, Yoo CG, Kim YW, et al. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug- resistant tuberculosis. Clin Infect Dis 2007;45: 1290-5
DOI
ScienceOn
|
3 |
Harrow EM, Rangel JM, Arriega JM, Cohen I, Regil Ruiz MI, DeRiemer K, et al. Epidemiology and clinical consequences of drug-resistant tuberculosis in a Guatemalan hospital. Chest 1998;113:1452-8
DOI
ScienceOn
|
4 |
Sharma SK, Turaga KK, Balamurugan A, Saha PK, Pandey RM, Jain NK, et al. Clinical and genetic risk factors for the development of multi-drug resistant tuberculosis in non-HIV infected patients at a tertiary care center in India: a case-control study. Infect Genet Evol 2003;3:183-8
DOI
ScienceOn
|
5 |
World Health Organization. Guidelines for the programmatic management of drug-resistant pulmonary tuberculosis. Geneva: World Health Organization; 2006
|
6 |
Arevalo M, Solera J, Cebrian D, Bartolome J, Robles P. Risk factors associated with drug-resistant Mycobacterium tuberculosis in Castilla-la-Mancha (Spain). Eur Respir J 1996;9:274-8
DOI
|
7 |
Caminero JA. Management of multidrug-resistant tuberculosis and patients in retreatment. Eur Respir J 2005; 25:928-36
DOI
ScienceOn
|
8 |
Faustini A, Hall AJ, Perucci CA. Risk factors for multi- drug resistant tuberculosis in Europe: a systematic review. Thorax 2006;61:158-63
DOI
ScienceOn
|
9 |
Raviglione M. XDR-TB: entering the post-antibiotic era? Int J Tuberc Lung Dis 2006;10:1185-7
|
10 |
Kordy FN, Al-Thawadi S, Alrajhi AA. Drug resistance patterns of Mycobacterium tuberculosis in Riyadh, Saudi Arabia. Int J Tuberc Lung Dis 2004;8:1007-11
|
11 |
Iseman MD. Treatment of multidrug-resistant tuberculosis. N Engl J Med 1993;329:784-91
DOI
ScienceOn
|
12 |
Choi JC, Lim SY, Suh GY, Chung MP, Kim HJ, Kwon OJ, et al. Drug resistance rates of Mycobacterium tuberculosis at a private referral center in Korea. J Korean Med Sci 2007;22:677-81
DOI
ScienceOn
|
13 |
Djuretic T, Herbert J, Drobniewski F, Yates M, Smith EG, Magee JG, et al. Antibiotic resistant tuberculosis in the United Kingdom: 1993-1999. Thorax 2002;57: 477-82
DOI
|
14 |
Centers for disease control and prevention. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs-worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep 2006;55:301-5
|
15 |
Kim HJ, Kang CH, Kim YT, Sung SW, Kim JH, Lee SM, et al. Prognostic factors for surgical resection in patients with multidrug-resistant tuberculosis. Eur Respir J 2006;28:576-80
DOI
ScienceOn
|
16 |
Colebunders R, Apers L, Shamputa IC. Treatment of multidrug-resistant tuberculosis. Lancet 2004;363:1240
|
17 |
Kang YA, Choi YJ, Cho YJ, Lee SM, Yoo CG, Kim YW, et al. Cost of treatment for multidrug-resistant tuberculosis in South Korea. Respirology 2006;11:793-8
DOI
ScienceOn
|
18 |
Mukherjee JS, Rich ML, Socci AR, Joseph JK, Virú FA, Shin SS, et al. Programmes and principles in treatment of multidrug-resistant tuberculosis. Lancet 2004;363: 474-81
DOI
ScienceOn
|
19 |
Leimane V, Riekstina V, Holtz TH, Zarovska E, Skripconoka V, Thorpe LE, et al. Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study. Lancet 2005;365:318-26
DOI
|
20 |
Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, et al. Extensively drug resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006;368:1575-80
DOI
ScienceOn
|
21 |
Jeon CY, Hwang SH, Min JH, Prevots DR, Goldfeder LC, Lee H, et al. Extensively drug-resistant tuberculosis in South Korea: risk factors and treatment outcomes among patients at a tertiary referral hospital. Clin Infect Dis 2008;46:42-9
DOI
ScienceOn
|
22 |
Dukes Hamilton C, Sterling TR, Blumberg HM, Leonard M, McAuley J, Schlossberg D, et al. Extensively drugresistant tuberculosis: are we learning from history or repeating it? Clin Infect Dis 2007;45:338-42
DOI
ScienceOn
|
23 |
Ruddy M, Balabanova Y, Graham C, Fedorin I, Malomanova N, Elisarova E, et al. Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia. Thorax 2005;60:130-5
DOI
ScienceOn
|
24 |
Yew WW, Chan CK, Chau CH, Tam CM, Leung CC, Wong PC, et al. Outcomes of patients with multidrug- resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin-containing regimens. Chest 2000; 117:744-51
DOI
ScienceOn
|